当前位置:首页 > 股票大全 > 和邦生物 603077 财务分析

和邦生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

和邦生物(603077)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,999,261,196.48,824,107,811.826,434,462,278.944,090,613,303.82
营业总成本1,944,326,999.847,325,629,073.215,261,021,840.033,368,929,779.36
营业利润43,612,198.851,541,792,116.141,210,602,688.47729,549,281.19
利润总额43,608,602.021,535,965,520.991,209,838,849.38728,835,852.35
净利润27,143,210.751,278,699,260.631,014,075,433.12603,141,895.11
其他综合收益1,488,590.7431,687,239.44-61,744.1814,074,680.68
综合收益总额28,631,801.491,310,386,500.071,014,013,688.94617,216,575.79
和邦生物(603077)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计10,808,114,490.39,854,626,292.0410,349,534,611.499,318,220,290.95
非流动资产合计14,830,900,085.2314,687,807,830.8114,511,425,379.8814,396,208,200.1
资产总计25,639,014,575.5324,542,434,122.8524,860,959,991.3723,714,428,491.05
流动负债合计5,090,318,548.143,669,941,850.663,568,883,373.823,101,355,859.38
非流动负债合计874,308,696.95654,110,050.9867,712,444.52581,769,500.65
负债合计5,964,627,245.094,324,051,901.564,436,595,818.343,683,125,360.03
归属于母公司股东权益合计19,033,820,331.8219,575,342,485.2819,778,680,624.3419,393,137,463.84
股东权益合计19,674,387,330.4420,218,382,221.2920,424,364,173.0320,031,303,131.02
负债和股东权益合计25,639,014,575.5324,542,434,122.8524,860,959,991.3723,714,428,491.05
和邦生物(603077)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,401,050,252.766,438,680,798.864,807,753,614.283,392,839,753.51
经营活动现金流出小计1,834,423,591.336,358,349,014.534,660,057,473.033,053,700,924.45
经营活动产生的现金流量净额-433,373,338.5780,331,784.33147,696,141.25339,138,829.06
投资活动现金流入小计4,911,030.97280,497,909.28121,557,333.913,936,341.65
投资活动现金流出小计244,612,808.671,062,724,494.23793,921,565.46441,815,973.21
投资活动产生的现金流量净额-239,701,777.7-782,226,584.95-672,364,231.55-437,879,631.56
筹资活动现金流入小计1,531,191,082.471,858,723,703.991,498,714,556.18743,711,568.99
筹资活动现金流出小计1,111,827,029.552,802,320,418.971,797,914,114.491,577,100,184.77
筹资活动产生的现金流量净额419,364,052.92-943,596,714.98-299,199,558.31-833,388,615.78
汇率变动对现金及现金等价物的影响-73,739.745,465,273.5113,754,613.917,568,584.76
现金及现金等价物净增加额-253,784,803.09-1,640,026,242.09-810,113,034.71-914,560,833.52
期末现金及现金等价物余额2,651,047,038.992,904,831,842.083,734,745,049.463,630,297,250.65
和邦生物603077相关数据
今日股市大盘指数